Therefore, we studied DMD mRNA and protein expression across various normal tissues and matching tumors, and explored transcriptomic alterations in primary tumors and corresponding tumor cell lines with altered DMD expression to identify putative downstream molecular pathways that could be associated with DMD dysregulation across human tissues. The gene discussed is DMD; the disease is neoplasm.